marvels of
modern science

Biologics have revolutionalized treatment
of diseases such as rheumatoid arthritis,
Crohn's disease, psoriasis and certain types
of cancers. Biosimilar medicines offer
physicians additional therapeutic options
to essential, but often expensive,
reference products.

what is a biosimilar?

Biologics are highly complex and often expensive therapies.

  • A biosimilar is a biologic drug deemed highly similar to an already approved biologic drug, known as the reference biologic.
  • Biosimilars are authorized for use by Health Canada using the same rigorous regulatory standards for quality, efficacy, and safety as for all other biologic drugs.1
  • A biosimilar manufacturer must demonstrate that its proposed biosimilar product has no clinically meaningful differences from the reference product in terms of safety, quality, and effectiveness.